StemSpan™ B细胞生成试剂盒

用于将人脐带血来源的CD34+ HSPCs扩增并分化为B细胞和抗体分泌细胞的完全试剂盒

率先评论此产品

产品号 #（选择产品）

产品号 #100-1250_C

用于将人脐带血来源的CD34+ HSPCs扩增并分化为B细胞和抗体分泌细胞的完全试剂盒

产品优势

从CD34+ HSPCs中获得高得率和高比例的CD19+ B细胞和抗体分泌细胞；
获得能够分泌抗体的功能性B细胞；
无需使用血清、饲养层细胞或包被材料即可持续生成B细胞

产品组分包括

StemSpan™B细胞分化添加物1 (20X), 2.5 mL；
StemSpan™B细胞分化添加物2 (20X), 2.5 mL；
StemSpan™B细胞分化添加物3 (20X), 0.625 mL；
StemSpan™B细胞分化添加物4 (20X), 0.625 mL；
StemSpan™SFEM II, 2 × 100 mL

跳到结尾的图片库

跳转到图像库的开头

总览

使用此优化的三步工作流程，可从脐带血来源的CD34+造血干祖细胞（HSPCs）中可重复地生成B细胞和抗体分泌细胞（ASCs）。StemSpan™ B细胞生成试剂盒不含血清且无需饲养层，可提高实验的一致性，并提高B细胞和IgM ASCs的诱导生成比例和得率。StemSpan™ B细胞分化添加物1（20X）包含重组细胞因子和其他添加物，用于选择性地促进从脐带血分离的CD34+细胞扩增并分化为B淋巴样祖细胞。接着，StemSpan™ B细胞分化添加物2 （20X）可提供额外的刺激，使B淋巴样祖细胞进一步分化为B细胞祖细胞。最后，使用StemSpan™ B细胞分化添加物3 （20X）和StemSpan™ B细胞分化添加物4 （20X）选择性地将B细胞祖细胞分化为B细胞和ASCs。StemSpan™ B细胞生成试剂盒用于与StemSpan™无血清扩增培养基II （SFEM II）搭配使用。为了您的方便，所有试剂盒组分都可以单独购买。

实验数据

Figure 1. StemSpan™ B Cell Generation Protocol

Cord blood-derived CD34+ HSPCs are seeded on Day 0 in StemSpan™ SFEM II (Catalog #09605) containing StemSpan™ B Cell Differentiation Supplement 1 (Catalog #100-1251) and cultured for 14 days, followed by StemSpan™ SFEM II containing StemSpan™ B Cell Differentiation Supplement 2 (Catalog #100-1252) for an additional 14 days. Medium should be topped up after 3 - 4 days of culture followed by two half-medium changes every 3 - 4 days. On Day 28, cells are harvested and reseeded in StemSpan™ SFEM II containing StemSpan™ B Cell Differentiation Supplement 3 (Catalog #100-1253), followed by a top up with StemSpan™ SFEM II containing StemSpan™ B Cell Differentiation Supplement 4 (Catalog #100-1254) after 3 days for further differentiation to B cells.

Flow Cytometry of CD34+ cells (freshly isolated or from cryopreserved stock) were cultured in StemSpan™ SFEM II containing StemSpan™ B Cell Differentiation Supplement 1 for 14 days.

Figure 2. B Lymphoid Progenitors Are Contained Within the Lineage Negative Cell Population After 14 Days of Culture

Cord blood-derived CD34+ cells (freshly isolated or from cryopreserved stock) were cultured in StemSpan™ SFEM II (Catalog # 09605) containing StemSpan™ B Cell Differentiation Supplement 1 (Catalog #100-1251) for 14 days. (A-D) Cells were harvested and analyzed by flow cytometry for the presence of lineage-negative cells (Lin-, to exclude non-B lineage cells) and the expression of B lymphoid progenitor markers including CD34, CD10, CD19, and CD24. A small population of early B cell progenitors (which may contain proB and preB cells) can be detected on gated Lin- cells. (E) The average frequency of Lin- cells on Day 14 was 36.6 ± 1.4% with a yield of 47.1 ± 3.2 Lin- cells per input CD34+ cell. The graph shows mean with standard error (n = 36).

Flow cytometry and bar graphs showing the frequency and yield of CD19+ B cells after 28 days of culture

Figure 3. Frequency and Yield of CD19+ B Cells After 28 Days of Culture

Day 14 B lymphoid progenitors were further differentiated into CD19+ B cells by culturing for an additional 14 days in StemSpan™ SFEM II (Catalog #09605) containing StemSpan™ B Cell Differentiation Supplement 2 (Catalog #100-1252). (A-D) Cells were harvested and analyzed by flow cytometry for expression of CD10, CD19, CD20, CD24, and IgM within the Lin- cell population to detect later-stage B cell progenitors, containing PreB cells and a small population of IgM+ immature B cells. (E) The average frequency of CD19+ cells on Day 28 was 21.3 ± 1.6% with a yield of 82.7 ± 11.5 CD19+ cells per input CD34+ cell. The graph shows mean with standard error (n = 36)

Flow cytometry and bar graphs showing the frequency and yield of CD19+IgM+ and antibody-secreting B cells after 35 days of culture

Figure 4. Frequency and Yield of CD19+IgM+ and Antibody-Secreting B Cells After 35 Days of Culture

On Day 28, CD19+ B cells were further differentiated into CD19+IgM+ and antibody-secreting cells (ASCs) by culturing for an additional 7 days in StemSpan™ SFEM II (Catalog #09605) containing StemSpan™ B Cell Differentiation Supplement 3 (Catalog #100-1253) followed by StemSpan™ SFEM II containing StemSpan™ B Cell Differentiation Supplement 4 (Catalog #100-1254). (A-D) On Day 35, cells were analyzed by flow cytometry for the expression of CD19, CD20, CD24, CD27, CD38, and IgM. (E) The frequency and yield of CD19+ (pan B cells), CD19+IgM+ (IgM+ B cells), and CD19+CD27+CD38++ B cells (memory-like B cells and ASCs) are shown. On average, the frequencies and yield per input CD34+ cells were 54.0 ± 2.7%;140.7 ± 19.1, 27.3% ± 1.3%; 65.3 ± 9.9, and 14.2% ± 1.3%; 36.5 ± 5.3, respectively. The graph shows means with standard error (n = 36).

ELISpot assays and bar graphs displaying antibody-secreting B cells generated after 35 days of culture

Figure 5. Antibody-Secreting B Cells Generated After 35 Days of Culture

On Day 35, immunoglobulin-secreting cell frequencies of cultured B cells were determined by ELISpot assay. (A) Images of dual ELISpot assays (CTL ImmunoSpot®, IgM/IgG and IgA/IgE) for the detection of IgM (red) and IgG (blue) or IgA (red) and IgE (blue) antibody-secreting B cells (StemSpan™ SFEM II with StemSpan™ B Cell Differentiation Supplements 3 and 4, right) compared to negative control (StemSpan™ SFEM II without StemSpan™ B Cell Differentiation Supplements 3 and 4, left); 10,000 culture Day 35 cells per well were used. IgE ASCs were not detected. (B) The frequency and yield of ASCs are shown. On average 610 ± 67, 5 ± 1, and 317 ± 47 cells per 10,000 Day 35 cells secrete IgM, IgG, and IgA antibodies with a yield of 16.2 ± 2.4, 0.1 ± 0.04, and 5.2 ± 1.7 per input CD34+ cell, respectively. The graph shows mean with standard error (n = 8 - 33).

产品说明书及文档

请在《产品说明书》中查找相关支持信息和使用说明，或浏览下方更多实验方案。

Document Type

Product Name

Catalog #

Lot #

Language

Document Type

Product Information Sheet

Product Name

StemSpan™ B Cell Generation Kit

Catalog #